Can Nanoparticles Protect You From Hepatitis-B?

A new research finds that nanotechnology can help administer administering Hepatitis-B vaccines. European and Brazilian researchers carried out the research to demonstrate the action of nano compounds. Study of the immune system complemented the research on oral vaccinations used against hepatitis-B. Antigen and silica particles play an important role in immunizing individuals against hepatitis-B. These particles combine with each other to travel to the human intestines without acidic agents blocking them.

Nanostructured silica helps in improving the immune system, and hence, researchers developed SBA-15 silica structures. Furthermore, the researchers also used surface antigens for hepatitis-B to understand human immunity. Various X-ray images of these antigens and nanoparticles were studied across European Laboratories. Researchers from Brazil’s Sao Paulo’s Physics Institute developed the nanostructured silica. Scientific Reports published the findings of the research.

Aim of Research Study

The primary goal of the researchers was to understand the binding of nanostructured silica with surface antigens. They found that the two elements combined to form structures similar to a honeycomb. Further, scientists used light scattering, X-ray scattering, and electron transmission to calculate the size of silica particles and antigens. Although the two particles differed in size, their combined impact produced a sound immune response.

Neutron and X-ray imaging were extensively deployed during the course of the research. Hence, the researchers obtained three-dimensional images that helped in understanding the synchronisation of antigens with silica structures. The antigens refrained from entering the nanotubes which caused them to avert the acidity of the digestive system.

Future Study and General Information

Researchers have determined the right amount of silica that should be blended with HBsAg particles to improve immunity. 257 million people worldwide live with hepatitis-B, according to the WHO. Researchers from France, Denmark, Germany, Switzerland, and Sweden collaborated for this research.

Author: Rohit Bhisey

As Head of Marketing at TMR Research, Rohit brings to the table over a decade of experience in market research and Internet marketing. His dedication, perseverance, and passion for perfection have enabled him to achieve immense success in his field. Rohit is an expert at formulating new business plans and strategies to help boost web traffic. His interests lie in writing news articles on technology,healthcare and business.

Leave a Reply